Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]

K. Brosen*, E. Skjelbo

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalBritish Journal of Clinical Pharmacology
Volume32
Issue number1
Pages (from-to)136-137
Number of pages2
ISSN0306-5251
DOIs
Publication statusPublished - Jul 1991

Cite this